These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


201 related items for PubMed ID: 27612991

  • 1. Doxapram Dosing for Apnea of Prematurity Based on Postmenstrual Age and Gender: A Randomized Controlled Trial.
    Greze E, Benard M, Hamon I, Casper C, Haddad FE, Boutroy MJ, Hascoët JM.
    Paediatr Drugs; 2016 Dec; 18(6):443-449. PubMed ID: 27612991
    [Abstract] [Full Text] [Related]

  • 2. Doxapram Treatment for Apnea of Prematurity: A Systematic Review.
    Vliegenthart RJ, Ten Hove CH, Onland W, van Kaam AH.
    Neonatology; 2017 Dec; 111(2):162-171. PubMed ID: 27760427
    [Abstract] [Full Text] [Related]

  • 3. Brain hemodynamic effects of doxapram in preterm infants.
    Dani C, Bertini G, Pezzati M, Pratesi S, Filippi L, Tronchin M, Rubaltelli FF.
    Biol Neonate; 2006 Dec; 89(2):69-74. PubMed ID: 16158005
    [Abstract] [Full Text] [Related]

  • 4. Low-dose doxapram therapy for idiopathic apnea of prematurity.
    Yamazaki T, Kajiwara M, Itahashi K, Fujimura M.
    Pediatr Int; 2001 Apr; 43(2):124-7. PubMed ID: 11285061
    [Abstract] [Full Text] [Related]

  • 5. Doxapram versus methylxanthine for apnea in preterm infants.
    Henderson-Smart DJ, Steer P.
    Cochrane Database Syst Rev; 2000 Apr; (2):CD000075. PubMed ID: 10796115
    [Abstract] [Full Text] [Related]

  • 6. Doxapram treatment for apnea in preterm infants.
    Henderson-Smart DJ, Steer PA.
    Cochrane Database Syst Rev; 2000 Apr; (2):CD000074. PubMed ID: 10796114
    [Abstract] [Full Text] [Related]

  • 7. Effect of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants.
    Poets CF, Darraj S, Bohnhorst B.
    Biol Neonate; 1999 Oct; 76(4):207-13. PubMed ID: 10473894
    [Abstract] [Full Text] [Related]

  • 8. Doxapram Treatment and Diaphragmatic Activity in Preterm Infants.
    de Waal CG, Hutten GJ, Kraaijenga JV, de Jongh FH, van Kaam AH.
    Neonatology; 2019 Oct; 115(1):85-88. PubMed ID: 30352445
    [Abstract] [Full Text] [Related]

  • 9. Long-Term Neurodevelopmental Outcome after Doxapram for Apnea of Prematurity.
    Ten Hove CH, Vliegenthart RJ, Te Pas AB, Brouwer E, Rijken M, van Wassenaer-Leemhuis AG, van Kaam AH, Onland W.
    Neonatology; 2016 Oct; 110(1):21-6. PubMed ID: 26967910
    [Abstract] [Full Text] [Related]

  • 10. Doxapram treatment for apnea in preterm infants.
    Henderson-Smart DJ, Steer PA.
    Cochrane Database Syst Rev; 2001 Oct; (4):CD000074. PubMed ID: 11687067
    [Abstract] [Full Text] [Related]

  • 11. Low-dose doxapram for treatment of apnoea following early weaning in very low birthweight infants: a randomized, double-blind study.
    Huon C, Rey E, Mussat P, Parat S, Moriette G.
    Acta Paediatr; 1998 Nov; 87(11):1180-4. PubMed ID: 9846921
    [Abstract] [Full Text] [Related]

  • 12. Doxapram versus methylxanthine for apnea in preterm infants.
    Henderson-Smart DJ, Steer P.
    Cochrane Database Syst Rev; 2000 Nov; (4):CD000075. PubMed ID: 11034672
    [Abstract] [Full Text] [Related]

  • 13. Doxapram treatment for apnea in preterm infants.
    Henderson-Smart D, Steer P.
    Cochrane Database Syst Rev; 2004 Oct 18; 2004(4):CD000074. PubMed ID: 15494987
    [Abstract] [Full Text] [Related]

  • 14. Aminophylline versus doxapram in idiopathic apnea of prematurity: a double-blind controlled study.
    Eyal F, Alpan G, Sagi E, Glick B, Peleg O, Dgani Y, Arad I.
    Pediatrics; 1985 Apr 18; 75(4):709-13. PubMed ID: 3982903
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of doxapram in idiopathic apnea of prematurity.
    Beaudry MA, Bradley JM, Gramlich LM, LeGatt D.
    Dev Pharmacol Ther; 1988 Apr 18; 11(2):65-72. PubMed ID: 3371147
    [Abstract] [Full Text] [Related]

  • 16. Low-dose doxapram therapy in premature infants and its CSF and serum concentrations.
    Kumita H, Mizuno S, Shinohara M, Ichikawa T, Yamazaki T.
    Acta Paediatr Scand; 1991 Apr 18; 80(8-9):786-91. PubMed ID: 1957596
    [Abstract] [Full Text] [Related]

  • 17. Doxapram for the initial treatment of idiopathic apnea of prematurity.
    Bairam A, Faulon M, Monin P, Vert P.
    Biol Neonate; 1992 Apr 18; 61(4):209-13. PubMed ID: 1610948
    [Abstract] [Full Text] [Related]

  • 18. Isolated mental developmental delay in very low birth weight infants: association with prolonged doxapram therapy for apnea.
    Sreenan C, Etches PC, Demianczuk N, Robertson CM.
    J Pediatr; 2001 Dec 18; 139(6):832-7. PubMed ID: 11743509
    [Abstract] [Full Text] [Related]

  • 19. Effect of doxapram on cerebral blood flow velocity in preterm infants.
    Roll C, Horsch S.
    Neuropediatrics; 2004 Apr 18; 35(2):126-9. PubMed ID: 15127312
    [Abstract] [Full Text] [Related]

  • 20. Clinical and physiological responses to prolonged nasogastric administration of doxapram for apnea of prematurity.
    Tay-Uyboco J, Kwiatkowski K, Cates DB, Seifert B, Hasan SU, Rigatto H.
    Biol Neonate; 1991 Apr 18; 59(4):190-200. PubMed ID: 2070020
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.